Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

British Journal of Pharmacology

Volumn 134, Issue 2, 2001, Pages 409-417

  Van Heek, M ^a   Farley, C ^a   Compton, D S ^a   Hoos, L ^a   Davis, H R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Absorption; Cholesterol; Hamster; Pancreas; Rat; Triglyceride fat soluble vitamins

Indexed keywords

BILE ACID; CHOLESTEROL; CHOLESTEROL ESTER; ETHINYLESTRADIOL; EZETIMIBE; FATTY ACID; PROGESTERONE; RETINOL; TAUROCHOLIC ACID; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; VITAMIN D;

ANASTOMOSIS; ARTICLE; BILE FLOW; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; EXOCRINE SECRETION; HYDROLYSIS; HYPERCHOLESTEROLEMIA; INTESTINE ABSORPTION; INTESTINE WALL; MALE; NONHUMAN; PANCREAS FUNCTION; PRIORITY JOURNAL;

EID: 0034776367     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704260     Document Type: Article

References (31)

1. The effect of acy1 CoA: Cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine
2. The hypocholesterolemic activity of the potent cholesterol absorption inhibitor SCH58235 alone and in combination with HMG CoA reductase inhibitors
3. The cholesterol absorption inhibitor ezetimibe (SCH58235) and lovastatin synergistically lower plasma cholesterol and inhibit the development of atherosclerosis
4. Intestinal cholesterol absorption
5. A simple method for isolation and purification of total lipides from animal tissues
6. Inhibition of ileal Na+/bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits
7. Established and emerging strategies for inhibition of cholesterol absorption
8. Postprandial lipoprotein metabolism and atherosclerosis
9. Effect of ezetimibe on serum concentrations of lipid-soluble vitamins
10. Coadministration of simvastatin and ezetimibe leads to significant reduction in LDL-cholesterol
11. Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor SCH 58235 and simvastatin
12. Role of pancreatic digestion in cholesterol absorption
13. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
14. Reduction of LDL-cholesterol and elevation of HDL-cholesterol in subjects with primary hypercholesterolemia by ezetimibe (SCH58235): Pooled analysis of two Phase II studies
15. Atherosclerosis as a post-prandial disease
16. Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk
17. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4- hydroxyphenyl)-2-azetidinone (SCH58235): A designed, potent, orally active inhibitor of cholesterol absorption
18. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
19. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
20. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
21. Inhibition of post prandial fat absorption with the MTP inhibitor Bay 13-9952
22. Effect of bay 13-9952, a microsomal triglyceride transfer protein inhibitor on lipids and lipoproteins in dyslipoproteinemic patients
23. Dietary cholesterol and the mechanisms of cholesterol absorption
24. Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese, hyperinsulinemic hamsters
25. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
26. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663
27. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461
28. The effect of pancreatic diversion on lymphatic absorption and esterification of cholesterol in the rat
29. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins